--Ionis Pharmaceuticals receives FDA Fast Track designation for olezarsen 07:06 IONS
--Mr. Mizuho is 'constructive' on Uber shares into Q4 results
--Harmonic price target raised to $20 from $17 at Barclays 06:08 HLIT
Apple iPhone sell-through down 12% in Q4, says UBS
--Mr. Mizuho is 'constructive' on Uber shares into Q4 results
--Harmonic price target raised to $20 from $17 at Barclays 06:08 HLIT
Apple iPhone sell-through down 12% in Q4, says UBS

